Attenuated SIV causes persisting neuroinflammation in the absence of a chronic viral load and neurotoxic antiretroviral therapy

AIDS

Volumn 30, Issue 16, 2016, Pages 2439-2448

  Ferguson, Deborah ^a   Clarke, Sean ^a   Berry, Neil ^a   Almond, Neil ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Acute infection; Cynomolgus macaques; HIV associated neurocognitive impairment; Neuropathology; Simian immunodeficiency virus; Suppressed viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CASPASE 3; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; FRONTAL LOBE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INOCULATION; MACACA FASCICULARIS; MACROPHAGE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRUS LOAD; VIRUS REPLICATION; ANIMAL; BRAIN; PATHOGENICITY; PATHOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS ENCEPHALITIS;

ANIMALS; BRAIN; ENCEPHALITIS, VIRAL; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84973402566     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001178     Document Type: Article

References (44)

1. Gonzalez-Scarano F, Marin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5:69-81.
2. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 2005; 12 (Suppl 1):878-892.
3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69:1789-1799.
4. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SA, LeBlanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011; 17:3-16.
5. Rao VR, Ruiz AP, Prasad VR. Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther 2014; 11:13.
6. Bell JE. An update on the neuropathology of HIV in the HAART era. Histopathology 2004; 45:549-559.
7. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005; 64:529-536.
8. Davies J, Everall IP, Weich S, Glass J, Sharer LR, Cho ES, et al. HIV-associated brain pathology: a comparative international study. Neuropathol Appl Neurobiol 1998; 24:118-124.
9. Clarke S, Berry N, Ham C, Alden J, Almond N, Ferguson D. Neuropathology of wild-type and nef-attenuated T cell tropic simian immunodeficiency virus (SIVmac32H) and macrophage tropic neurovirulent SIVmac17E-Fr in cynomolgus macaques. J Neurovirol 2012; 18:100-112.
10. Rud EW, Cranage M, Yon J, Quirk J, Ogilvie L, Cook N, et al. Molecular and biological characterisation of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J Gen Virol 1994; 75:529-543.
11. Li B, Berry N, Ham C, Ferguson D, Smith D, Hall J, et al. Vaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4RCCR5R T cells. Retrovirology 2011; 8:8.
12. Almond N, Kent K, Cranage M, Rud E, Clarke B, Stott EJ. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 1995; 345:1342-1344.
13. Cranage MP, Whatmore AM, Sharpe SA, Cook N, Polyanska N, Leech S, et al. Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa. Virology 1997; 229:143-154.
14. Clarke S, Almond N, Berry N. Simian immunodeficiency virus nef gene regulates the production of 2-LTR circles in vivo. Virology 2003; 306:100-108.
15. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements J. Molecular and biological characterisation of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol 1997; 71:5790-5798.
16. Berry N, Stebbings R, Ferguson D, Ham C, Alden J, Brown S, et al. Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). J Gen Virol 2008; 89:2240-2251.
17. Canto-Nogues C, Jones S, Sangster R, Silvera P, Hull R, Cook R, et al. In situ hybridisation and immunolabelling study of the early replication of simian immunodeficiency virus (SIVmacJ5) in vivo. J Gen Virol 2001; 82:2225-2234.
18. Berry N, Ham C, Alden J, Clarke S, Stebbings R, Stott J, et al. Live attenuated simian immunodeficiency virus vaccination confers superinfection resistance against macrophage-tropic and neurovirulent wild-type SIV challenge. J Gen Virol 2015; 96:1918-1929.
19. Berry N, Ham C, Mee ET, Rose NJ, Mattiuzzo G, Jenkins A, et al. Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques. PLoS One 2011; 6:e23092.
20. Ferguson D, Mattiuzzo G, Ham C, Stebbings R, Li B, Rose N, et al. Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissues. PLoS One 2014; 9:e104390.
21. Valcour V, Sithinamsuwan S, Letendre S, Ances B. Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 2011; 8:54-61.
22. Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL. HIVassociated neurocognitive disorder: pathogenesis and therapeutic opportunities. J Neuroimmune Pharmacol 2010; 5:294-309.
23. Babas T, Munoz D, Mankowski JL, Tarwater PM, Clements JE, Zink MC. Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain. J Virol 2003; 77:208-216.
24. Orandle MS, MacLean AG, Sasseville VG, Alvarex X, Lackner AA. Enhanced expression of proinflammatory cytokines in the central nervous system is associated with neuroinvasion by simian immunodeficiency virus and the development of encephalitis. J Virol 2002; 76:5797-5802.
25. Overholser ED, Coleman GD, Bennett JL, Casaday RJ, Zink MC, Barber SA, et al. Expression of simian immunodeficiency virus (SIV) Nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J Virol 2003; 77:6855-6866.
26. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brain of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001; 193:905-915.
27. Ivey NS, MacLean AG, Lackner AA. AIDS and the blood-brain barrier. J Neurovirol 2009; 15:111-122.
28. Fiala M, Looney DJ, Stins M, Way DD, Zhang L, Gan X, et al. TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med 1997; 3:553-564.
29. MacLean AG, Belenchia GE, Bieniemy DN, Moroney-Rasmussen TA, Lackner AA. Simian immunodeficiency virus disrupts extended lengths of the blood-brain barrier. J Med Primatol 2005; 34:237-242.
30. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999; 155:1915-1927.
31. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992; 32:658-666.
32. Gray F, Belec L, Chretien F, Dubreuil-Lemaire ML, Ricolfi F, Wingertsmann L, et al. Acute, relapsing brain oedema with diffuse blood-brain barrier alteration and axonal damage in the acquired immunodeficiency syndrome. Neuropathol Appl Neurobiol 1998; 24:209-216.
33. Smith WL, DeWitt DI, Garavito RM. Cyclooxygenases: structural, cellular and molecular biology. Annu Rev Biochem 2000; 69:145-182.
34. Bosetti F. Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models. J Neurochem 2007; 102:577-586.
35. Griffin DE, Wesselingh SL, McArthur JC. Elevated central nervous system prostaglandins in human immunodeficiency virus associated dementia. Ann Neurol 1994; 35:592-597.
36. Maihofner C, Probst-Cousin S, Bergmann M, Neuhuber W, Neundorfer B, Heuss D. Expression and localisation of cyclooxygenase-1 and-2 in human sporadic amyotrophic lateral sclerosis. Eur J Neurosci 2003; 18:1527-1534.
37. Hoozemans JJ, Rozemuller JM, van Haastert ES, Veerhuis R, Eikelenboom P. Cyclooxygenase-1 and-2 in the different stage of Alzheimers disease pathology. Curr Pharm Des 2008; 14:1419-1427.
38. Depboylu C, Weihe E, Eiden LE. COX1 and COX2 expression in nonneuronal cellular compartments of the rhesus macaque brain during lentiviral infection. Neurobiol Dis 2011; 42:108-115.
39. Schmidley JW, Dadson J, Iyer RS, Salomon RG. Brain tissue injury and blood-brain barrier opening induced by injection of LGE2 or PGE2. Prostaglandins Leukot Essent Fatty Acids 1992; 47:105-110.
40. Legler DF, Krause P, Scandella E, Singer E, Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol 2006; 176:966-973.
41. Tajima T, Murata T, Aritake K, Urade Y, Hirai H, Nakamura M, et al. Lippopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). J Pharmacol Exp Ther 2008; 326:493-501.
42. Renner NA, Sansing HA, Morici LA, Inglis FM, Lackner AA, MacLean AG. Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion. J Neurovirol 2012; 18:213-221.
43. Depboylu C, Weihe E, Eiden LE. Lentiviral infection of rhesus macaques causes long-term injury to cortical and hippocampal projections of prostaglandin-expressing cholinergic basal forebrain neurons. J Neuropathol Exp Neurol 2012; 71:15-27.
44. Das AT, Klaver B, Harwig A, Vink M, Ooms M, Centlivre M, et al. Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of Tat in viral replication. J Virol 2007; 81:11159-11169.